In chronic hepatitis, which complications and management considerations are expected?

In chronic hepatitis, which complications and management considerations are expected?

• A. Cirrhosis with hepatic encephalopathy, varices, ascites, and edema.
• B. Acute kidney injury only.
• C. Isolated anemia.
• D. Pulmonary edema only.

Answer: (A)

Chronic hepatitis often progresses to cirrhosis, which creates a combination of portal hypertension and liver failure that drives several classic complications. Hepatic encephalopathy develops when the damaged liver can’t adequately detoxify gut-derived toxins like ammonia, leading to cognitive changes, sleep disturbances, and personality/neurologic symptoms; management focuses on reducing ammonia production and absorption with lactulose and, if needed, rifaximin, while addressing precipitating factors. Portal hypertension from cirrhosis leads to esophageal and gastric varices that can bleed, so patients are routinely screened and managed to prevent or treat variceal hemorrhage—nonselective beta-blockers can reduce portal pressure, endoscopic variceal ligation may be used for high-risk varices, and any bleeding is treated with vasoactive medications, antibiotics, and supportive care. Ascites results from increased portal pressure and decreased oncotic pressure from hypoalbuminemia, requiring sodium restriction and diuretic therapy (spironolactone is typically first-line, with furosemide added as needed); tense ascites may need therapeutic paracentesis, and monitoring is important to prevent or treat infections like spontaneous bacterial peritonitis. Edema likewise reflects fluid retention from these mechanisms and is managed with diuretics and treatment of the underlying portal hypertension. In advanced disease, evaluating for liver transplantation becomes a key consideration. The other options don’t reflect this spectrum of complications—noting that while acute kidney injury or other issues can occur, they don’t represent the typical, systemic set of problems seen with chronic hepatitis progressing to cirrhosis.

Chronic hepatitis often progresses to cirrhosis, which creates a combination of portal hypertension and liver failure that drives several classic complications. Hepatic encephalopathy develops when the damaged liver can’t adequately detoxify gut-derived toxins like ammonia, leading to cognitive changes, sleep disturbances, and personality/neurologic symptoms; management focuses on reducing ammonia production and absorption with lactulose and, if needed, rifaximin, while addressing precipitating factors. Portal hypertension from cirrhosis leads to esophageal and gastric varices that can bleed, so patients are routinely screened and managed to prevent or treat variceal hemorrhage—nonselective beta-blockers can reduce portal pressure, endoscopic variceal ligation may be used for high-risk varices, and any bleeding is treated with vasoactive medications, antibiotics, and supportive care. Ascites results from increased portal pressure and decreased oncotic pressure from hypoalbuminemia, requiring sodium restriction and diuretic therapy (spironolactone is typically first-line, with furosemide added as needed); tense ascites may need therapeutic paracentesis, and monitoring is important to prevent or treat infections like spontaneous bacterial peritonitis. Edema likewise reflects fluid retention from these mechanisms and is managed with diuretics and treatment of the underlying portal hypertension. In advanced disease, evaluating for liver transplantation becomes a key consideration. The other options don’t reflect this spectrum of complications—noting that while acute kidney injury or other issues can occur, they don’t represent the typical, systemic set of problems seen with chronic hepatitis progressing to cirrhosis.